Guillain-Barré Syndrome Warning Added to Shingrix Vaccine in Australia
In February 2024, Australia’s Therapeutic Goods Administration (TGA), the country’s national regulatory authority for drugs and, initiated an investigation into a potential association between GSK plc’s Shingrix shingles vaccine, Guillain-Barré syndrome (GBS), which causes inflammation and damage to the nerves, that may include paralysis.1 The investigation was prompted by two reports of GBS following Shingrix […]
FDA Lab Uncovers Excess DNA Contamination in COVID-19 Vaccines
An explosive new study conducted within the U.S. Food and Drug Administration’s (FDA) own laboratory has revealed excessively high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine. Tests conducted at the FDA’s White Oak Campus in Maryland found that residual DNA levels exceeded regulatory safety limits by 6 to 470 times. The study was undertaken […]
Triathlete Who Suffered Torn Coronary Artery Days After COVID Shots Undergoes More Surgery
In mid-2021, triathlete and fitness instructor Ingi Doyle of Queensland, Australia received two doses of the Pfizer/BioNTech Comirnaty mRNA (messenger ribonucleic acid) COVID-19 biologic. The first shot on June 12, 2021 left her with a sore arm. After the second shot on July 4, she developed a severe adverse reaction that resulted in an aortic […]
Evidence of Alarming Growth in Cognitive Impairment Among Adults
According to research conducted in Netherlands by the Network for Health Research in Disasters (GOR Network), a significant number of adults are increasingly grappling with unexplained memory and concentration problems. The findings show an alarming 24 percent spike in doctor visits related to cognitive impairment issues among people 25 years and older during the first […]
Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]